Stryker Corporation vs Johnson & Johnson
SYK vs JNJ — side-by-side comparison from reported financials. SYK leads 4, JNJ leads 6 of 10 comparable metrics.
Stryker Corporation
SYK · Healthcare
$277.70+0.26%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | SYK | JNJ |
|---|---|---|
| Price | $277.70 | $261.79 |
| Market cap | $107B | $631B |
| Revenue (TTM) | $25.8B | $97.9B |
| Revenue growth | +10.8% | +5.6% |
| Net margin | 14.4% | 21.5% |
| Free cash flow | $4.70B | $22.2B |
| Net cash (debt) | ($11.8B) | ($27.8B) |
| 1-year price return | -25.0% | +37.0% |
| P/E | 28.5 | 29.9 |
| P/E vs own history (cheap-side %) | 99% | 16% |
| Dividend yield | 1.24% | 2.00% |
| Return on equity | 16% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 56,000 | 140,800 |
Full résumé-style profiles: SYK CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.